Applying Guideline-Directed Care For Patients With T2D: Focus on Glucagon-Like Peptide-1 Receptor Agonists

Create Account

Availability

On-Demand

Expires on Dec 31, 2025

Cost

$0.00

Credit Offered

1.5 AOA Category 1-A Credits

OBJECTIVES
After participating in this session, attendees will be able to:

Explain how glucagon-like peptide-1 receptor agonists (GLP-1 RAs) function in treating type 2 diabetes (T2D) and their extra-glycemic effects
Examine safety considerations related to GLP-1 RAs and explore effective approaches for addressing adverse events associated with their use
Evaluate the guidance for comprehensive approaches to care and early management of T2D Expiration

Speakers: Kathleen Dungan, MD, MPH; Jay Schubrook, DO, FACOFP

Expiration Date: November 5, 2027

This activity is designated for a maximum of 1.5 AOA Category 1-A Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This educational activity is supported by an independent educational grant from Novo Nordisk, Inc.